All news

Gilead CFO sells 3,000 shares near record highs

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Gilead Sciences CFO Andrew Dickinson sold 3,000 shares of company stock for $468,660 under a pre-arranged trading plan, retaining 161,096 shares. The sale occurred as Gilead's stock traded near record highs, driven by investor rotation into defensive pharmaceutical companies. Analyst sentiment remains largely positive, with a "Moderate Buy" rating and an average price target of

Read original source

GILD company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.